胰岛素样蛋白3(INSL3)重组蛋白
Recombinant Insulin Like Protein 3 (INSL3)
RLNL; RLF; Relaxin-Like Factor,Leydig Cell; Leydig insulin-like peptide
- 编号RPD873Hu01
- 物种Homo sapiens (Human，人) 相同的名称，不同的物种。
- 来源原核表达
- 宿主E.coli
- 内毒素水平<1.0EU/µg(LAL法测定)
- 亚细胞定位分泌
- 预测分子量17.8kDa
- 实际分子量18kDa(差异分析请参阅说明书)
- 片段与标签Asp2~Cys129 with N-terminal His Tag
- 缓冲液成份20mM Tris, 150mM NaCl缓冲液（pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300）
- 性状冻干粉
- 纯度> 95%
- 等电点9.5
-
应用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，请参见活性蛋白。 - 下载 英文说明书 中文说明书
- 规格 10µg50µg 200µg 1mg 5mg
- 价格 ¥ 984 ¥ 2460 ¥ 4920 ¥ 14760 ¥ 36900
- 欲了解实际交易价格和更多情况，请与当地经销商联系!
-
产品包装(模拟)
-
产品包装(模拟)
-
SDS-PAGE图
-
通过ISO 9001、ISO 13485质量体系认证
序列
用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
储存
避免反复冻融。2-8°C不超过一个月，-80°C不超过12个月。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。
增值服务
相关产品
| 编号 | 适用物种：Homo sapiens (Human，人) | 应用(仅供研究使用，不用于临床诊断！) |
| RPD873Hu01 | 胰岛素样蛋白3(INSL3)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAD873Hu01 | 胰岛素样蛋白3(INSL3)多克隆抗体 | WB; IHC; ICC; IP. |
| MAD873Hu21 | 胰岛素样蛋白3(INSL3)单克隆抗体 | WB; IHC; ICC; IP. |
| SED873Hu | 胰岛素样蛋白3(INSL3)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMD873Hu | 胰岛素样蛋白3(INSL3)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
| 杂志 | 参考文献 |
| Adv Med Sci. | Are anti-MĂźllerian hormone and its receptor polymorphism associated with the hormonal condition of undescended testes? [Pubmed:27162065] |
| Journal of Clinical Research in Pediatric Endocrinology | Anti-Müllerian Hormone and Inhibin-A, but not Inhibin-B or Insulin-Like Peptide-3, may be Used as Surrogates in the Diagnosis of Polycystic Ovary Syndrome in Adolescents: Preliminary Results. [pubmed:27125339] |
| Bioscience, Biotechnology, and Biochemistry | Salivary lactoferrin is transferred into the brain via the sublingual route [pubmed:28351211] |
| Seed canals. Leydig and Sertoli cells function in patients with genital ambiguity [] |
留言咨询